Table 3.

MRI lesion-based detection rate of target biopsies (n = 135).

	Any cancer∗ % (n/n)	Significant cancer∗∗ % (n/n)
PiRADS score
5	83.0 (10/12)	75.0 (9/12)
4	45.0 (18/40)	35.0 (14/40)
3	18.0 (10/55)	13.0 (7/55)
2	6.0 (1/16)	6.0 (1/16)
Unclassified	25.0 (3/12)	17.0 (2/12)

PiRADS: Prostate imaging Reporting and Detection System.

∗: prostate cancer with any Gleason grade; ∗∗: prostate cancer with Gleason grade ≥ 4.